Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 2
2009 2
2010 1
2011 1
2012 4
2013 3
2014 4
2015 3
2016 5
2017 4
2018 4
2019 2
2020 3
2021 6
2022 9
2023 5
2024 9
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy.
Martín M, Stecklein SR, Gluz O, Villacampa G, Monte-Millán M, Nitz U, Cobo S, Christgen M, Brasó-Maristany F, Álvarez EL, Echavarría I, Conte B, Kuemmel S, Bueno-Muiño C, Jerez Y, Kates R, Cebollero M, Kolberg-Liedtke C, Bueno O, García-Saenz JÁ, Moreno F, Grischke EM, Forstbauer H, Braun M, Warm M, Hackmann J, Uleer C, Aktas B, Schumacher C, Wuerstleins R, Graeser M, Zu Eulenburg C, Kreipe HH, Gómez H, Massarrah T, Herrero B, Paré L, Bohn U, López-Tarruella S, Vivancos A, Sanfeliu E, Parker JS, Perou CM, Villagrasa P, Prat A, Sharma P, Harbeck N. Martín M, et al. Among authors: cobo s. Ann Oncol. 2025 Feb;36(2):158-171. doi: 10.1016/j.annonc.2024.10.012. Epub 2024 Oct 16. Ann Oncol. 2025. PMID: 39419289 Free article.
Breast Cancer Patient's Outcomes after Neoadjuvant Chemotherapy and Surgery at 5 and 10 Years for Stage II-III Disease.
Falo C, Azcarate J, Fernandez-Gonzalez S, Perez X, Petit A, Perez H, Vethencourt A, Vazquez S, Laplana M, Ales M, Stradella A, Fullana B, Pla MJ, Gumà A, Ortega R, Varela M, Pérez D, Ponton JL, Cobo S, Benitez A, Campos M, Fernández A, Villanueva R, Obadia V, Recalde S, Soler-Monsó T, Lopez-Ojeda A, Martinez E, Ponce J, Pernas S, Gil-Gil M, Garcia-Tejedor A. Falo C, et al. Among authors: cobo s. Cancers (Basel). 2024 Jun 30;16(13):2421. doi: 10.3390/cancers16132421. Cancers (Basel). 2024. PMID: 39001483 Free PMC article.
Acoustic emissions from spin crossover complexes.
Kamel SM, Daróczi L, Tóth LZ, Beke DL, Juárez GG, Cobo S, Salmon L, Molnár G, Bousseksou A. Kamel SM, et al. Among authors: cobo s. J Mater Chem C Mater. 2024 Mar 19;12(16):5757-5765. doi: 10.1039/d4tc00495g. eCollection 2024 Apr 25. J Mater Chem C Mater. 2024. PMID: 38680543 Free PMC article.
Stromal tumor infiltrating lymphocytes and TNBC-DX provide complementary prognostic information in triple-negative breast cancer.
Stecklein SR, Martín M, Villacampa G, Del Monte-Millan M, Yoder R, Pathak H, Cobo S, Brasó-Maristany F, Álvarez EL, Echavarría I, Bueno-Muiño C, Jerez Y, Cebollero M, Bueno O, García-Saenz JÁ, Moreno F, Gómez HL, Massarrah T, Herrero B, Paré L, Marín-Aguilera M, Buckingham W, López-Tarruella S, Villagrasa P, Godwin AK, Salgado R, Prat A, Sharma P. Stecklein SR, et al. Among authors: cobo s. J Natl Cancer Inst. 2025 Jul 2:djaf162. doi: 10.1093/jnci/djaf162. Online ahead of print. J Natl Cancer Inst. 2025. PMID: 40600921
Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer.
Angelats L, Paré L, Rubio-Perez C, Sanfeliu E, González A, Seguí E, Villacampa G, Marín-Aguilera M, Pernas S, Conte B, Albarrán-Fernández V, Martínez-Sáez O, Aguirre Á, Galván P, Fernandez-Martinez A, Cobo S, Rey M, Martínez-Romero A, Walbaum B, Schettini F, Vidal M, Buckingham W, Muñoz M, Adamo B, Agrawal Y, Guedan S, Pascual T, Agudo J, Grzelak M, Borcherding N, Heyn H, Vivancos A, Parker JS, Villagrasa P, Perou CM, Prat A, Brasó-Maristany F. Angelats L, et al. Among authors: cobo s. ESMO Open. 2025 Jan;10(1):104109. doi: 10.1016/j.esmoop.2024.104109. Epub 2025 Jan 6. ESMO Open. 2025. PMID: 39765189 Free PMC article.
Dithienylethene-Based Single Molecular Photothermal Linear Actuator.
Rashid U, Chatir E, Medrano Sandonas L, Sreelakshmi PA, Dianat A, Gutierrez R, Cuniberti G, Cobo S, Kaliginedi V. Rashid U, et al. Among authors: cobo s. Angew Chem Int Ed Engl. 2023 Apr 11;62(16):e202218767. doi: 10.1002/anie.202218767. Epub 2023 Mar 6. Angew Chem Int Ed Engl. 2023. PMID: 36752105
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
Hardt K, Vandebosch A, Sadoff J, Le Gars M, Truyers C, Lowson D, Van Dromme I, Vingerhoets J, Kamphuis T, Scheper G, Ruiz-Guiñazú J, Faust SN, Spinner CD, Schuitemaker H, Van Hoof J, Douoguih M, Struyf F; ENSEMBLE2 study group. Hardt K, et al. Lancet Infect Dis. 2022 Dec;22(12):1703-1715. doi: 10.1016/S1473-3099(22)00506-0. Epub 2022 Sep 13. Lancet Infect Dis. 2022. PMID: 36113538 Free PMC article. Clinical Trial.
Prevalence and clinical impact of germline pathogenic variants in breast cancer: a descriptive large single-center study.
Rodriguez-Hernandez A, Martínez-Sáez O, Brasó-Maristany F, Conte B, Gómez R, García-Fructuoso I, Fratini B, Segui E, Potrony M, Sanfeliu E, Cobo S, Galvan P, Moreno L, Grau E, Aceituno MR, Puig-Butille JA, Oriola J, Goberna G, Blasco P, Castillo O, Sirenko V, Aguirre A, Vidal M, Muñoz M, Ramon Y Cajal T, Balaguer F, Prat A, Adamo B. Rodriguez-Hernandez A, et al. Among authors: cobo s. ESMO Open. 2025 Apr;10(4):104543. doi: 10.1016/j.esmoop.2025.104543. Epub 2025 Apr 9. ESMO Open. 2025. PMID: 40209283 Free PMC article.
69 results